Shuban Pharmaceuticals Private Limited
About Shuban Pharmaceuticals Private Limited
Data last updated:
Shuban Pharmaceuticals Private Limited is a private limited company based in Bhiwandi, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2007PTC170245. Its GSTIN is 27AADCR8742A1ZH (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Run Pharmaceuticals Private Limited. It is led by directors Ratnakar Pandarinath Mehendre and Sonali Ratnakar Mehendre.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at I – 115 Rajlaxmi Commercial Complex 1st Floor Kalher Bhiwandi Thane, Maharashtra, India – 421302.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.17 Lakh, a growth of 62% compared to the previous year. For the same year it recorded a net profit of ₹48,688 (net margin 3%) and EBITDA of ₹91,092 (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Shuban Pharmaceuticals Private Limited's registered office is in Bhiwandi, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressI – 115 Rajlaxmi Commercial Complex 1st Floor Kalher Bhiwandi Thane, Maharashtra, India – 421302
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shuban Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shuban Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Shuban Pharmaceuticals Private Limited, buy the company report.
Financials of Shuban Pharmaceuticals Private Limited
FY 2025 filings availableShuban Pharmaceuticals Private Limited reported revenue of ₹16.17 Lakh (up 62% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over three years, including 62% growth in the latest year. EBITDA rose 330% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹91,092 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹48,688 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shuban Pharmaceuticals Private Limited, buy the company report.
Board of directors of Shuban Pharmaceuticals Private Limited
Shuban Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ratnakar Pandarinath Mehendre | Director | 24 Apr 2007 | 19 Years 6 Months | Current |
| Sonali Ratnakar Mehendre | Director | 24 Apr 2007 | 19 Years 6 Months | Current |
Peer comparison
Shuban Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ajapa Pharma Private Limited | ₹16.2 Lakh (FY 2020) | 120.0% | Hyderabad, Telangana, India | |||
| Aadison Pharma Private Limited | ₹16.19 Lakh (FY 2023) | 18.0% | Pune, Maharashtra, India | |||
| Premolian Formulations (OPC) Private Limited | ₹16.17 Lakh (FY 2019) | Jammu, Jammu and Kashmir, India | ||||
| Shuban Pharmaceuticals Private Limitedthis company | ₹16.17 Lakh (FY 2025) | ₹48,688 | 3% | 62.0% | Bhiwandi, Maharashtra, India |
To see the full peer comparison of Shuban Pharmaceuticals Private Limited, buy the company report.
Auditor
Shuban Pharmaceuticals Private Limited is audited by UMESH S PATWARI & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| UMESH S PATWARI & ASSOCIATES | FY 2018 | 116795W |
Shareholding
The shareholding of Shuban Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Shuban Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Shuban Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shuban Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shuban Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCR8742A1ZH | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Shuban Pharmaceuticals Private Limited, buy the company report.
Recent activity
Shuban Pharmaceuticals Private Limited has 2 board changes on record since 2007: 2 appointments. The latest: Ratnakar Pandarinath Mehendre was appointed as Director on 24 Apr 2007.
Frequently asked questions
Shuban Pharmaceuticals is an active private limited company based in Bhiwandi, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 April 2007 (19+ years old) and is registered under CIN U24100MH2007PTC170245.
Shuban Pharmaceuticals has 2 current directors:
- Ratnakar Pandarinath Mehendre - Director
- Sonali Ratnakar Mehendre - Director
The latest financial statements of Shuban Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Shuban Pharmaceuticals is 27AADCR8742A1ZH, registered in Maharashtra.
The CIN (Corporate Identification Number) of Shuban Pharmaceuticals is U24100MH2007PTC170245. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shuban Pharmaceuticals was incorporated on 24 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Shuban Pharmaceuticals by revenue are Ajapa Pharma Private Limited, Aadison Pharma Private Limited, Premolian Formulations (OPC) Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ratnakar Pandarinath Mehendre was appointed as Director on 24 Apr 2007. Sonali Ratnakar Mehendre was appointed as Director on 24 Apr 2007.
The registered office of Shuban Pharmaceuticals is at I – 115 Rajlaxmi Commercial Complex 1st Floor Kalher Bhiwandi Thane, Maharashtra, India – 421302.
Shuban Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Shuban Pharmaceuticals is compliant as of 09 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
